Karine Rutault

Karine Rutault is an experienced clinical project director with a strong background in immunotherapy and clinical research. Currently, Karine serves as Director of Clinical Projects at DBV Technologies since September 2012, leading studies focused on desensitization of food-allergic patients through epicutaneous immunotherapy (Viaskin). Prior to this role, Karine held the position of Associate Director Clinician at Pfizer Global R&D, where responsibilities included leading Phase 4 and Phase 2 studies in psoriasis and rheumatoid arthritis, respectively. With earlier roles as Assistant Director Clinical Scientist at Wyeth Pharmaceuticals and Research Associate at the University of Oxford, Karine specializes in clinical development and pre-clinical research, particularly in the fields of dermatology, immunology, and biochemistry, holding a PhD in Biochemistry from University Lyon I.